Microplastics in Stool of Breastfed and Non-breastfed Infants – A Prospective Case Series
- Conditions
- Existence of microplastics in stool of children
- Registration Number
- DRKS00024741
- Lead Sponsor
- Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting withdrawn before recruiting started
- Sex
- All
- Target Recruitment
- 30
Male and female children (aged 0-12 months) are included if parents confirm that stool of their children can be used of the investigation of the existence of microplastics.
Parents have signed the written informed consent after being informed in detail about the nature, risks, and scope of the study and any expected desirable and potential adverse effects.
Neither legally incapacitated nor subject to any other circumstances rendering the parents unable to understand the nature, scope, and possible consequences of the study.
- Medical diet
- Diarrhoea or obstipation
- Antibiotics taken within the last two weeks
- Drugs affecting stool frequency and consistency (e.g. loperamide)
- Drugs affecting resorption (e.g. activated charcoal, cholestyramine)
- Diagnosed gastrointestinal disease (e.g. Ulcerative colitis, Crohn's disease)
- Mother with breast implants
- For breastfed infants – used of a nipple shield
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The existence of microplastics in the stool of the infants will be the primary outcome parameter.
- Secondary Outcome Measures
Name Time Method Secondary endpoints will include the amount and type of microplastics in breastfed infants (without soothers) compared to breastfed infants with soothers and baby-bottle fed infants with soothers.